Home Politics Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity
Politics

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity
Key Points

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter. The financing, which will be announced as soon as Wednesday, will help BridgeBio accelerate the launch of new drugs intended to treat genetic diseases, according to the people, who asked not to be identified because they’re not authorized to...

Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity Sixth Street Partners and KKR & Co. have agreed to provide $1 billion of preferred equity to biotechnology company BridgeBio Pharma Inc., according to people with knowledge of the matter. The financing, which will be announced as soon as Wednesday, will help BridgeBio accelerate the launch of new drugs intended to treat genetic diseases, according to the people, who asked not to be identified because they’re not authorized to speak publicly. [Image text:] 45 91 OPEN KK 00
Sixth Street (ORG) KKR (ORG) KKR & Co. (ORG) BridgeBio Pharma Inc. (ORG)
Originally published by Bloomberg Markets Read original →